Laurus Labs Q1 FY27 Results: Revenue ₹2,026 Cr, Profit ₹362 Cr
Laurus Labs reported unaudited Q1 FY27 results with total revenue at ₹2,026.31 crore, up from ₹1,811.57 crore in Q4 FY26. Net profit after tax was ₹362.07 crore, a significant rise from ₹282.09 crore in Q4 FY26. EPS stood at ₹6.81.
The significant year-on-year and quarter-on-quarter growth in revenue and profit is material information for investors.
The company reported a strong increase in revenue and net profit for the quarter compared to the previous quarter and the same quarter last year.
Laurus Labs Limited has announced its unaudited financial results for the quarter ended June 30, 2026. The company reported a total revenue from operations of ₹2,026.31 crore, a significant increase from ₹1,811.57 crore in the previous quarter (March 31, 2026) and ₹1,569.57 crore in the corresponding quarter of the previous year (June 30, 2025).
The net profit for the period, before tax and exceptional/extraordinary items, stood at ₹481.36 crore. After accounting for taxes, the net profit after tax was ₹362.07 crore for the quarter ended June 30, 2026. This represents a notable improvement compared to ₹282.09 crore in the previous quarter and ₹161.68 crore in the same quarter last year.
Total comprehensive income for the period attributable to equity holders of the company was ₹359.86 crore. The company's equity share capital remained stable at ₹108.05 crore. Earnings per share (EPS) for the quarter were ₹6.81 (basic) and ₹6.80 (diluted).
For the year ended March 31, 2026, the company reported a total revenue from operations of ₹6,812.90 crore and a net profit after tax of ₹890.14 crore.
The financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on July 24, 2026. The detailed financial results are available on the websites of the stock exchanges and the company.
What to do with a filing like this
Laurus Labs Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Laurus Labs Limited. Read the original for the full detail.